[English] 日本語
Yorodumi
- PDB-7mnl: Crystal structure of the N-terminal domain of NUP358/RanBP2 (resi... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 7mnl
TitleCrystal structure of the N-terminal domain of NUP358/RanBP2 (residues 1-752) in complex with Fab fragment
Components
  • Antibody Fab14 Heavy Chain
  • Antibody Fab14 Light Chain
  • E3 SUMO-protein ligase RanBP2
KeywordsTRANSFERASE/Immune System / NUCLEAR PORE COMPLEX COMPONENT / NUCLEOCYTOPLASMIC TRANSPORT / TRANSPORT PROTEIN / TRANSFERASE-Immune System complex
Function / homology
Function and homology information


cytoplasmic periphery of the nuclear pore complex / SUMO ligase activity / SUMO ligase complex / annulate lamellae / nuclear pore cytoplasmic filaments / Nuclear Pore Complex (NPC) Disassembly / nuclear inclusion body / nuclear pore nuclear basket / Transport of Ribonucleoproteins into the Host Nucleus / Regulation of Glucokinase by Glucokinase Regulatory Protein ...cytoplasmic periphery of the nuclear pore complex / SUMO ligase activity / SUMO ligase complex / annulate lamellae / nuclear pore cytoplasmic filaments / Nuclear Pore Complex (NPC) Disassembly / nuclear inclusion body / nuclear pore nuclear basket / Transport of Ribonucleoproteins into the Host Nucleus / Regulation of Glucokinase by Glucokinase Regulatory Protein / Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) / Transport of the SLBP independent Mature mRNA / Transport of the SLBP Dependant Mature mRNA / NS1 Mediated Effects on Host Pathways / SUMOylation of SUMOylation proteins / Transport of Mature mRNA Derived from an Intronless Transcript / Transferases; Acyltransferases; Aminoacyltransferases / Rev-mediated nuclear export of HIV RNA / SUMOylation of RNA binding proteins / nuclear export / Nuclear import of Rev protein / Transport of Mature mRNA derived from an Intron-Containing Transcript / NEP/NS2 Interacts with the Cellular Export Machinery / tRNA processing in the nucleus / SUMO transferase activity / nucleocytoplasmic transport / centrosome localization / Viral Messenger RNA Synthesis / regulation of gluconeogenesis / NLS-bearing protein import into nucleus / SUMOylation of ubiquitinylation proteins / Vpr-mediated nuclear import of PICs / SUMOylation of DNA replication proteins / protein sumoylation / Regulation of HSF1-mediated heat shock response / mRNA transport / Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal / SUMOylation of DNA damage response and repair proteins / nuclear pore / Mitotic Prometaphase / EML4 and NUDC in mitotic spindle formation / Resolution of Sister Chromatid Cohesion / response to amphetamine / SUMOylation of chromatin organization proteins / GTPase activator activity / HCMV Late Events / RHO GTPases Activate Formins / Transcriptional regulation by small RNAs / Signaling by ALK fusions and activated point mutants / ISG15 antiviral mechanism / small GTPase binding / HCMV Early Events / Separation of Sister Chromatids / protein folding / nuclear envelope / snRNP Assembly / nuclear membrane / intracellular membrane-bounded organelle / protein-containing complex binding / SARS-CoV-2 activates/modulates innate and adaptive immune responses / RNA binding / nucleoplasm / membrane / metal ion binding / cytosol / cytoplasm
Similarity search - Function
Nup358/RanBP2 E3 ligase domain / Nup358/RanBP2 E3 ligase domain / Ran binding protein RanBP1-like / Ran binding domain / RanBP1 domain / Ran binding domain type 1 profile. / Ran-binding domain / Zinc finger domain / Zn-finger in Ran binding protein and others / Zinc finger RanBP2 type profile. ...Nup358/RanBP2 E3 ligase domain / Nup358/RanBP2 E3 ligase domain / Ran binding protein RanBP1-like / Ran binding domain / RanBP1 domain / Ran binding domain type 1 profile. / Ran-binding domain / Zinc finger domain / Zn-finger in Ran binding protein and others / Zinc finger RanBP2 type profile. / Zinc finger RanBP2-type signature. / Zinc finger, RanBP2-type superfamily / Zinc finger, RanBP2-type / Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site / Cyclophilin-type peptidyl-prolyl cis-trans isomerase signature. / Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain profile. / Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain / Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD / Cyclophilin-like domain superfamily / TPR repeat region circular profile. / TPR repeat profile. / Tetratricopeptide repeats / Tetratricopeptide repeat / Tetratricopeptide-like helical domain superfamily / PH-like domain superfamily
Similarity search - Domain/homology
E3 SUMO-protein ligase RanBP2
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 3.95 Å
AuthorsBley, C.J. / Nie, S. / Mobbs, G.W. / Petrovic, S. / Gres, A.T. / Liu, X. / Mukherjee, S. / Harvey, S. / Huber, F.M. / Lin, D.H. ...Bley, C.J. / Nie, S. / Mobbs, G.W. / Petrovic, S. / Gres, A.T. / Liu, X. / Mukherjee, S. / Harvey, S. / Huber, F.M. / Lin, D.H. / Brown, B. / Tang, A.W. / Rundlet, E.J. / Correia, A.R. / Chen, S. / Regmi, S.G. / Stevens, T.A. / Jette, C.A. / Dasso, M. / Patke, A. / Palazzo, A.F. / Kossiakoff, A.A. / Hoelz, A.
Funding support United States, 3items
OrganizationGrant numberCountry
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)GM117360 United States
Howard Hughes Medical Institute (HHMI)55108534 United States
Heritage Medical Research Institute United States
CitationJournal: Science / Year: 2022
Title: Architecture of the cytoplasmic face of the nuclear pore.
Authors: Christopher J Bley / Si Nie / George W Mobbs / Stefan Petrovic / Anna T Gres / Xiaoyu Liu / Somnath Mukherjee / Sho Harvey / Ferdinand M Huber / Daniel H Lin / Bonnie Brown / Aaron W Tang / ...Authors: Christopher J Bley / Si Nie / George W Mobbs / Stefan Petrovic / Anna T Gres / Xiaoyu Liu / Somnath Mukherjee / Sho Harvey / Ferdinand M Huber / Daniel H Lin / Bonnie Brown / Aaron W Tang / Emily J Rundlet / Ana R Correia / Shane Chen / Saroj G Regmi / Taylor A Stevens / Claudia A Jette / Mary Dasso / Alina Patke / Alexander F Palazzo / Anthony A Kossiakoff / André Hoelz /
Abstract: INTRODUCTION The subcellular compartmentalization of eukaryotic cells requires selective transport of folded proteins and protein-nucleic acid complexes. Embedded in nuclear envelope pores, which are ...INTRODUCTION The subcellular compartmentalization of eukaryotic cells requires selective transport of folded proteins and protein-nucleic acid complexes. Embedded in nuclear envelope pores, which are generated by the circumscribed fusion of the inner and outer nuclear membranes, nuclear pore complexes (NPCs) are the sole bidirectional gateways for nucleocytoplasmic transport. The ~110-MDa human NPC is an ~1000-protein assembly that comprises multiple copies of ~34 different proteins, collectively termed nucleoporins. The symmetric core of the NPC is composed of an inner ring encircling the central transport channel and outer rings formed by Y‑shaped coat nucleoporin complexes (CNCs) anchored atop both sides of the nuclear envelope. The outer rings are decorated with compartment‑specific asymmetric nuclear basket and cytoplasmic filament nucleoporins, which establish transport directionality and provide docking sites for transport factors and the small guanosine triphosphatase Ran. The cytoplasmic filament nucleoporins also play an essential role in the irreversible remodeling of messenger ribonucleoprotein particles (mRNPs) as they exit the central transport channel. Unsurprisingly, the NPC's cytoplasmic face represents a hotspot for disease‑associated mutations and is commonly targeted by viral virulence factors. RATIONALE Previous studies established a near-atomic composite structure of the human NPC's symmetric core by combining (i) biochemical reconstitution to elucidate the interaction network between symmetric nucleoporins, (ii) crystal and single-particle cryo-electron microscopy structure determination of nucleoporins and nucleoporin complexes to reveal their three-dimensional shape and the molecular details of their interactions, (iii) quantitative docking in cryo-electron tomography (cryo-ET) maps of the intact human NPC to uncover nucleoporin stoichiometry and positioning, and (iv) cell‑based assays to validate the physiological relevance of the biochemical and structural findings. In this work, we extended our approach to the cytoplasmic filament nucleoporins to reveal the near-atomic architecture of the cytoplasmic face of the human NPC. RESULTS Using biochemical reconstitution, we elucidated the protein-protein and protein-RNA interaction networks of the human and cytoplasmic filament nucleoporins, establishing an evolutionarily conserved heterohexameric cytoplasmic filament nucleoporin complex (CFNC) held together by a central heterotrimeric coiled‑coil hub that tethers two separate mRNP‑remodeling complexes. Further biochemical analysis and determination of a series of crystal structures revealed that the metazoan‑specific cytoplasmic filament nucleoporin NUP358 is composed of 16 distinct domains, including an N‑terminal S‑shaped α‑helical solenoid followed by a coiled‑coil oligomerization element, numerous Ran‑interacting domains, an E3 ligase domain, and a C‑terminal prolyl‑isomerase domain. Physiologically validated quantitative docking into cryo-ET maps of the intact human NPC revealed that pentameric NUP358 bundles, conjoined by the oligomerization element, are anchored through their N‑terminal domains to the central stalk regions of the CNC, projecting flexibly attached domains as far as ~600 Å into the cytoplasm. Using cell‑based assays, we demonstrated that NUP358 is dispensable for the architectural integrity of the assembled interphase NPC and RNA export but is required for efficient translation. After NUP358 assignment, the remaining 4-shaped cryo‑ET density matched the dimensions of the CFNC coiled‑coil hub, in close proximity to an outer-ring NUP93. Whereas the N-terminal NUP93 assembly sensor motif anchors the properly assembled related coiled‑coil channel nucleoporin heterotrimer to the inner ring, biochemical reconstitution confirmed that the NUP93 assembly sensor is reused in anchoring the CFNC to the cytoplasmic face of the human NPC. By contrast, two CFNCs are anchored by a divergent mechanism that involves assembly sensors located in unstructured portions of two CNC nucleoporins. Whereas unassigned cryo‑ET density occupies the NUP358 and CFNC binding sites on the nuclear face, docking of the nuclear basket component ELYS established that the equivalent position on the cytoplasmic face is unoccupied, suggesting that mechanisms other than steric competition promote asymmetric distribution of nucleoporins. CONCLUSION We have substantially advanced the biochemical and structural characterization of the asymmetric nucleoporins' architecture and attachment at the cytoplasmic and nuclear faces of the NPC. Our near‑atomic composite structure of the human NPC's cytoplasmic face provides a biochemical and structural framework for elucidating the molecular basis of mRNP remodeling, viral virulence factor interference with NPC function, and the underlying mechanisms of nucleoporin diseases at the cytoplasmic face of the NPC. [Figure: see text].
History
DepositionMay 1, 2021Deposition site: RCSB / Processing site: RCSB
Revision 1.0Jun 15, 2022Provider: repository / Type: Initial release
Revision 1.1Jun 22, 2022Group: Database references / Category: citation / citation_author
Item: _citation.journal_volume / _citation.page_first ..._citation.journal_volume / _citation.page_first / _citation.page_last / _citation.pdbx_database_id_PubMed / _citation.title / _citation_author.identifier_ORCID / _citation_author.name
Revision 1.2Oct 18, 2023Group: Data collection / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / pdbx_initial_refinement_model / struct_ncs_dom_lim
Item: _struct_ncs_dom_lim.beg_auth_comp_id / _struct_ncs_dom_lim.beg_label_asym_id ..._struct_ncs_dom_lim.beg_auth_comp_id / _struct_ncs_dom_lim.beg_label_asym_id / _struct_ncs_dom_lim.beg_label_comp_id / _struct_ncs_dom_lim.beg_label_seq_id / _struct_ncs_dom_lim.end_auth_comp_id / _struct_ncs_dom_lim.end_label_asym_id / _struct_ncs_dom_lim.end_label_comp_id / _struct_ncs_dom_lim.end_label_seq_id

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: E3 SUMO-protein ligase RanBP2
B: E3 SUMO-protein ligase RanBP2
H: Antibody Fab14 Heavy Chain
L: Antibody Fab14 Light Chain
K: Antibody Fab14 Heavy Chain
M: Antibody Fab14 Light Chain


Theoretical massNumber of molelcules
Total (without water)270,1166
Polymers270,1166
Non-polymers00
Water0
1
A: E3 SUMO-protein ligase RanBP2
H: Antibody Fab14 Heavy Chain
L: Antibody Fab14 Light Chain


Theoretical massNumber of molelcules
Total (without water)135,0583
Polymers135,0583
Non-polymers00
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
2
B: E3 SUMO-protein ligase RanBP2
K: Antibody Fab14 Heavy Chain
M: Antibody Fab14 Light Chain


Theoretical massNumber of molelcules
Total (without water)135,0583
Polymers135,0583
Non-polymers00
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Unit cell
Length a, b, c (Å)161.420, 161.420, 644.723
Angle α, β, γ (deg.)90.000, 90.000, 120.000
Int Tables number179
Space group name H-MP6522
Symmetry operation#1: x,y,z
#2: x-y,x,z+5/6
#3: y,-x+y,z+1/6
#4: -y,x-y,z+2/3
#5: -x+y,-x,z+1/3
#6: x-y,-y,-z
#7: -x,-x+y,-z+1/3
#8: -x,-y,z+1/2
#9: y,x,-z+2/3
#10: -y,-x,-z+1/6
#11: -x+y,y,-z+1/2
#12: x,x-y,-z+5/6
Noncrystallographic symmetry (NCS)NCS domain:
IDEns-IDDetails
11(chain L and resid 2 through 213)
21chain M
12chain H
22chain K
13(chain A and ((resid 147 and (name N or name...
23(chain B and resid 147 through 673)
14(chain A and resid 674 through 752)
24(chain B and resid 674 through 752)

NCS domain segments:
Dom-IDComponent-IDEns-IDBeg auth comp-IDBeg label comp-IDEnd auth comp-IDEnd label comp-IDSelection detailsAuth asym-IDLabel asym-IDAuth seq-IDLabel seq-ID
111ASPASPGLYGLY(chain L and resid 2 through 213)LD2 - 2132 - 213
211ASPASPGLYGLYchain MMF2 - 2132 - 213
112GLUGLUVALVALchain HHC4 - 2304 - 230
212GLUGLUVALVALchain KKE4 - 2304 - 230
113TRPTRPTRPTRP(chain A and ((resid 147 and (name N or name...AA147148
123ARGARGGLUGLU(chain A and ((resid 147 and (name N or name...AA3 - 7524 - 753
133ARGARGGLUGLU(chain A and ((resid 147 and (name N or name...AA3 - 7524 - 753
143ARGARGGLUGLU(chain A and ((resid 147 and (name N or name...AA3 - 7524 - 753
153ARGARGGLUGLU(chain A and ((resid 147 and (name N or name...AA3 - 7524 - 753
213TRPTRPSERSER(chain B and resid 147 through 673)BB147 - 673148 - 674
114ILEILEGLUGLU(chain A and resid 674 through 752)AA674 - 752675 - 753
214ILEILEGLUGLU(chain B and resid 674 through 752)BB674 - 752675 - 753

NCS ensembles :
ID
1
2
3
4

-
Components

#1: Protein E3 SUMO-protein ligase RanBP2 / 358 kDa nucleoporin / Nuclear pore complex protein Nup358 / Nucleoporin Nup358 / Ran-binding ...358 kDa nucleoporin / Nuclear pore complex protein Nup358 / Nucleoporin Nup358 / Ran-binding protein 2 / RanBP2 / p270


Mass: 86322.734 Da / Num. of mol.: 2 / Mutation: I599M
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: RANBP2, NUP358 / Production host: Escherichia coli (E. coli)
References: UniProt: P49792, Transferases; Acyltransferases; Aminoacyltransferases
#2: Antibody Antibody Fab14 Heavy Chain


Mass: 25476.312 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Production host: Escherichia coli (E. coli)
#3: Antibody Antibody Fab14 Light Chain


Mass: 23258.783 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Production host: Escherichia coli (E. coli)

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 4.49 Å3/Da / Density % sol: 72.6 %
Crystal growTemperature: 294 K / Method: vapor diffusion, hanging drop / pH: 4.6
Details: 3% (w/v) PEG 4,000; 0.15 M sodium acetate; 0.1 M sodium citrate

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 23-ID-B / Wavelength: 1.0331 Å
DetectorType: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Oct 9, 2018
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1.0331 Å / Relative weight: 1
ReflectionResolution: 3.95→19.97 Å / Num. obs: 44627 / % possible obs: 99.2 % / Redundancy: 39.7 % / CC1/2: 0.999 / Rmerge(I) obs: 0.379 / Rpim(I) all: 0.06 / Rrim(I) all: 0.384 / Net I/σ(I): 10.3 / Num. measured all: 1772720
Reflection shell

Diffraction-ID: 1

Resolution (Å)Redundancy (%)Rmerge(I) obsNum. measured allNum. unique obsCC1/2Rpim(I) allRrim(I) allNet I/σ(I) obs% possible all
3.95-4.138.65.88117690245850.4550.9515.959199.8
14.77-19.9735.10.069210365990.9990.0120.0748.760

-
Processing

Software
NameVersionClassification
PHENIX1.17.1refinement
PHASERphasing
XDSdata reduction
Cootmodel building
PDB_EXTRACTdata extraction
XSCALEdata processing
XSCALEdata scaling
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 4GA0, 5CWS

4ga0

5cws


Resolution: 3.95→19.97 Å / SU ML: 0.45 / Cross valid method: THROUGHOUT / σ(F): 1.33 / Phase error: 24.54 / Stereochemistry target values: ML
RfactorNum. reflection% reflection
Rfree0.2414 2213 4.97 %
Rwork0.1921 42270 -
obs0.1946 44483 99.93 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso max: 528.19 Å2 / Biso mean: 224.2133 Å2 / Biso min: 69.82 Å2
Refinement stepCycle: final / Resolution: 3.95→19.97 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms17358 0 0 0 17358
Num. residues----2219
Refine LS restraints NCS
Ens-IDDom-IDAuth asym-IDNumberRefine-IDRmsType
11L1914X-RAY DIFFRACTION6.579TORSIONAL
12M1914X-RAY DIFFRACTION6.579TORSIONAL
21H2010X-RAY DIFFRACTION6.579TORSIONAL
22K2010X-RAY DIFFRACTION6.579TORSIONAL
31A4670X-RAY DIFFRACTION6.579TORSIONAL
32B4670X-RAY DIFFRACTION6.579TORSIONAL
41A714X-RAY DIFFRACTION6.579TORSIONAL
42B714X-RAY DIFFRACTION6.579TORSIONAL
LS refinement shell

Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / Total num. of bins used: 16 / % reflection obs: 100 %

Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkNum. reflection all
3.95-4.030.29781210.271725972718
4.03-4.130.30631240.266825802704
4.13-4.230.31641420.249825852727
4.23-4.340.27961540.238125562710
4.34-4.470.26371220.212526072729
4.47-4.610.27521380.193926182756
4.61-4.770.26031530.198525792732
4.77-4.960.23861340.192426052739
4.96-5.180.26951510.193326192770
5.18-5.450.25321440.195126092753
5.45-5.790.22991390.186326522791
5.79-6.220.25241370.195726612798
6.22-6.820.23281360.190526592795
6.82-7.760.23111230.174827222845
7.76-9.590.20151390.153627382877
9.59-19.970.2271560.19128833039
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL11 (°2)L12 (°2)L13 (°2)L22 (°2)L23 (°2)L33 (°2)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T11 (Å2)T12 (Å2)T13 (Å2)T22 (Å2)T23 (Å2)T33 (Å2)Origin x (Å)Origin y (Å)Origin z (Å)
12.1182-1.9666-0.45021.3987-0.19160.71430.075-0.32690.1058-0.1915-0.16670.60250.11810.1174-0.00011.75990.2756-0.10051.00250.16060.8789-40.6319-49.4289-49.2354
20.5141-0.8862-0.01511.1367-1.63340.15340.53160.32650.30820.1739-0.26310.10150.0998-0.1745-0.00011.820.5185-0.00641.1898-0.0691.0078-38.02-28.7145-31.6804
31.1237-0.098-0.24251.3169-0.82512.7888-0.073-0.5098-0.2753-0.4995-0.28520.04080.42730.1884-0.00141.44050.1785-0.07590.65280.10060.9279-53.7703-40.4241-13.8599
40.7521-0.5519-0.96550.65870.25371.83460.2489-0.08450.0313-0.1008-0.20380.08820.1728-0.2661-01.1092-0.0664-0.10220.8150.01450.8656-72.9142-15.0375-2.5521
51.92931.26051.07351.01190.14670.543-0.26360.14870.3903-0.0009-0.16950.0207-0.12360.549801.27910.0722-0.00110.88990.13071.0614-41.776723.0745-19.4233
60.75040.9928-0.46781.3472.08191.10760.13110.3248-0.29430.2727-0.1435-0.2677-0.3106-0.012801.4782-0.40240.08541.62110.44021.8051-8.975429.3877-7.8854
72.0193-0.57810.14591.79460.00140.76580.2446-0.0275-0.0081-0.3683-0.206-0.21480.04740.1007-01.17560.1150.08550.90080.15620.9628-38.78961.379-18.1385
80.4091-1.04870.09480.4941-0.2924-0.20080.02970.1448-0.120.0843-0.3007-0.90370.11590.3908-01.1637-0.1886-0.10731.25750.30471.2445-14.747118.52932.8629
9-0.4986-0.24390.867-0.46180.4122-0.1798-0.4669-0.376-0.14631.162-0.0716-0.7634-0.81030.2847-02.39250.1246-0.48451.81430.1592.04388.9618-43.2281-29.7448
101.8531-1.3154-0.24181.1478-1.67482.7789-0.1210.0818-0.0140.15150.11820.0212-0.4971-0.215301.33510.2006-0.04510.76210.00820.9457-8.1406-48.3434-45.4448
110.99040.11060.44581.1490.5040.94950.03080.1393-0.0870.14680.0788-0.0113-0.2982-0.268300.91110.18580.01650.76380.11940.815-6.9926-79.8859-50.6409
121.2672-0.99120.29090.08311.29410.8558-0.4511-0.0541-0.00340.4256-0.2734-0.64180.32580.298101.7370.3093-0.10931.28710.18911.562738.0746-94.0758-30.4507
131.102-0.9244-1.75790.72231.68211.10090.0418-0.8184-0.3508-0.1871-0.4818-0.01840.50290.6098-01.24550.1144-0.30571.82530.59912.412770.019-85.4085-42.0246
141.4296-0.64060.2582.3706-0.74342.0495-0.49520.02450.77180.134-0.0112-0.4484-0.11180.0397-01.07020.0006-0.31090.67130.20871.254830.6105-74.0228-34.882
150.1085-0.08340.10840.1252-0.2121.0306-0.34980.15120.4892-0.0031-0.088-0.71130.08030.308301.39580.0213-0.05122.06930.68082.519361.5698-80.2422-54.72
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection detailsAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1chain 'A' and (resid 3 through 141 )A3 - 141
2X-RAY DIFFRACTION2chain 'A' and (resid 142 through 254 )A142 - 254
3X-RAY DIFFRACTION3chain 'A' and (resid 255 through 463 )A255 - 463
4X-RAY DIFFRACTION4chain 'A' and (resid 464 through 752 )A464 - 752
5X-RAY DIFFRACTION5chain 'L' and (resid 2 through 111 )L2 - 111
6X-RAY DIFFRACTION6chain 'L' and (resid 112 through 214 )L112 - 214
7X-RAY DIFFRACTION7chain 'H' and (resid 4 through 123 )H4 - 123
8X-RAY DIFFRACTION8chain 'H' and (resid 124 through 230 )H124 - 230
9X-RAY DIFFRACTION9chain 'B' and (resid 147 through 287 )B147 - 287
10X-RAY DIFFRACTION10chain 'B' and (resid 288 through 455 )B288 - 455
11X-RAY DIFFRACTION11chain 'B' and (resid 456 through 752 )B456 - 752
12X-RAY DIFFRACTION12chain 'M' and (resid 2 through 110 )M2 - 110
13X-RAY DIFFRACTION13chain 'M' and (resid 111 through 213 )M111 - 213
14X-RAY DIFFRACTION14chain 'K' and (resid 4 through 128 )K4 - 128
15X-RAY DIFFRACTION15chain 'K' and (resid 129 through 230 )K129 - 230

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more